Objective: To report a case of tumoral calcinosis from secondary hyperparathyroidism and to describe its surgical management.
CASE REPORTS parathyroid tissue in the superior left thyroid bed. She was diagnosed with tumoral calcinosis secondary to chronic kidney disease. The masses progressed in size despite medical management, and she was referred to the Otorhinolaryngology -Head and Neck Surgery service for surgical treatment. Physical examination findings were confirmed radiographically. (Figure 3, 4 
, 5)
Bilateral parathyroid exploration, subtotal parathyroidectomy, right thyroid lobectomy with isthmusectomy, transcervical thymectomy and incision biopsy of the elbow mass were done in June 2014. ( Figure  6 ) Bilateral superior and inferior parathyroid glands were identified, the right superior measuring 2.8x2x2.1 cm (enlarged), left superior 2.6x1.6x0.7 cm (enlarged), right inferior 1x1x1 cm, and left inferior 1.2x1x1 cm. (Figure 7) The specimens were consistent with parathyroid tissue on frozen section. A subtotal or 3 ½ parathyroidectomy was then performed, preserving ½ of the left inferior parathyroid gland. A right thyroid lobectomy with isthmusectomy was performed following 
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Final histopathologic results showed parathyroid hyperplasia for the left superior and right superior parathyroid glands, and normal parathyroid tissue in the left inferior and right inferior tissue. ( Figure  8 ) No diagnostic abnormality was noted in the dissected right thyroid lobe. Thymic remnants and four reactive lymph nodes were detected in the sample obtained from transcervical thymectomy, with no note of ectopic parathyroid tissue. The right elbow mass yielded fibrovascular connective tissue with calcifications, consistent with tumoral calcinosis. (Figure 9 )
Post-operative calcium levels decreased to 1.7 mmol/L (from 2.69 mmol/L) and phosphorus levels to 2.03 mmol/L (from 2.94 mmol/L). Rapid intact parathyroid hormone (PTH) was not available at our institution and thus an intraoperative PTH was not obtained. However, PTH levels dropped from a pre-operative 1791pg/mL to 14.27pg/mL post-operatively. The patient developed hypocalcemic symptoms and healthcare-associated pneumonia, both of which were managed and resolved during her hospital stay. She was discharged on the 19 th postoperative day with a serum calcium level of 2.04 mmol/L.
The patient was maintained on oral calcium supplementation, and regular once to twice-weekly dialysis sessions. On follow-up, significant decrease in the size of her shoulder and elbow masses was noted, with her right shoulder mass being clinically undetectable four months post-operatively. (Figure 1, 2 ) At the eighth post-operative month, she reported near-total resolution of the masses. Post-operative radiography showed marked decrease in calcinosis for her elbows and shoulders. (Figure 3 ,4,5) Calcium levels have since normalized and she is currently awaiting a kidney transplant, which is the definitive management for her chronic kidney disease.
DISCUSSION
Tumoral calcinosis (TC) is a rare benign condition characterized by deposition of large hydroxyapatite or calcium phosphate crystals in periarticular soft tissue, usually around large joints. 1 It usually manifests the detection of a thyroid nodule measuring 0.6x0.5x0.5cm. Partial transcervical thymectomy by the Thoracocardiovascular Surgery service excised the left and right thymic horns with blunt dissection of intrathoracic thymic tissues beyond the innominate vein, obtaining a sample measuring 4.4x2.5x1.5 cm. Incision biopsy of the right elbow 
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Vol. 31 no. 1 January -June 2016 CASE REPORTS as a palpable asymptomatic tumor-like mass, with calcification limited to the soft tissues and not extending to erode underlying bony surfaces. The mechanism of calcinosis remains unknown; however, a pathogenesis-based classification of tumoral calcinosis describes three subtypes: 1) primary normophosphatemic, 2) primary hyperphosphatemic, and 3) secondary. 3 Secondary tumoral calcinosis occurs in patients who have a concurrent disease capable of causing soft tissue calcification--in this case, associated with the chronic kidney disease causing secondary hyperparathyroidism (SHPT). Renal insufficiency leads to reduced synthesis of 1,25-dihydroxy-Vitamin D and decreased phosphate excretion resulting in hypocalcemia and hyperphospatemia. Consequently, parathyroid hormone (PTH) secretion increases resulting in parathyroid cell hyperplasia. 4 The prevalence of periarticular calcinosis in chronic kidney disease patients is very small at 0.5-1.2%. 5 The lesions have also mostly been described as varying in size from 2-10mm. 6 This patient's tumoral calcinosis was much larger than commonly reported, with masses measuring 15x12x8cm at the largest, which led to mass-effect limitation of extremity mobility and problems with cosmesis. Primary conservative therapy for TC includes dialysis to address the underlying renal insufficiency, calcium supplementation, dietary phosphorus restriction and calcium-free phosphate binding agents, which possibly induce rapid mobilization of the bound calcium in the calcified mass. 7 However, our patient did not respond to initial medical management, despite good compliance and regular follow-up. Uremic calcinosis has been noted to occur more commonly in patients on hemodialysis for more than three years. 6 Our patient did present with the masses three years into dialysis, and thus failure of medical management was already a strong consideration.
Observational studies have estimated that up to 2.5% of patients on dialysis are eventually referred for parathyroidectomy each year. 8 
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The parathyroid glands help in maintaining calcium homeostasis by responding to changes in serum ionized calcium concentrations, and secrete PTH in response to a fall in serum calcium. 9 Parathyroidectomy has been recommended in patients who have persistent hyperparathyroidism. Complete regression of TC, as well as correction of hypercalcemia, have been observed in patients who underwent subtotal parathyroidectomy. [10] [11] [12] A major concern for the surgical management of the patient was achieving successful dissection of the parathyroid tissue involved. Secondary hyperparathyroidism has been known to persist or recur because of failure to locate supernumerary glands, which can be expected in 13% of patients with SHPT. 13 Repeat parathyroid exploration is associated with more complications compared to initial explorations, 14 and the most cost-effective and safest management of persistent or recurrent hyperparathyroidism is to avoid reoperation by performing a complete initial surgery. Localization studies such as ultrasound and sestamibi scanning are recommended, both of which the patient had pre-operatively. However, even sestamibi scanning may detect only between 35-65% of hyperplastic glands and identifies ectopic glands in around 5-10% of cases. 15 Thus, a significant factor in successful surgery lies in the intraoperative localization of parathyroid glands, as well as dissecting the most common ectopic sites.
Ectopic parathyroid tissue has been noted most commonly within the thymus, as a consequence of the extensive embryologic migration of the inferior parathyroid glands. 16 Routine thymectomy has not yet been established as a gold standard accompanying parathyroidectomy, but studies have shown promising results for the procedure. Intrathymic parathyroid tissue has been found in 33% of patients with hyperparathyroidism who underwent transcervical thymectomy, including supernumerary glands in 11%. 17 Intrathymic parathyroid tissue has also been found in 28.4% of patients who underwent re-operative parathyroidectomy due to persistent SHPT. 18 Transcervical thymectomy involves removing one or both cervical tongues of the thymus, with an estimated 30-40% of thymic tissue removed. Post-operative hypocalcemia has been reported in 51% of patients compared to 25% in those undergoing parathyroidectomy alone. Other precautions for thymectomy include limiting bleeding and risk of injury to the recurrent laryngeal nerves. However, the transcervical approach still results in a high yield of parathyroid tissue in a relatively non-invasive way, compared to routine thymectomy that necessitates a sternotomy. This approach was deemed ideal for the patient, who preferred a minimally invasive surgery that would also lessen her chances of needing a subsequent operation to locate missed parathyroid tissue.
Intrathyroidal parathyroid tissue has also been found in up to 10% of patients with ectopic parathyroid glands , 18 and right thyroid lobectomy and isthmusectomy was performed after detection of a right thyroid nodule intraoperatively. The decision to perform a lobectomy at that point was also to lessen the need for re-operation, should the nodule have turned out to be pathologic.
Post-operative issues encountered included transient hypocalcemia, which was managed with intravenous calcium infusion, and development of healthcare-associated pneumonia which was attributed to the prolonged hospital stay. However, these issues were resolved and the patient is still on regular follow-up with Otorhinolaryngology -Head and Neck Surgery, Endocrinology, Orthopedic, and Neprhology services. Since the operation, eight months post-operatively, she has had remarkable progress to complete resolution of her tumoral calcinosis, with both clinical and radiographic evidence.
Tumoral calcinosis may present as a rare and devastating complication of renal insufficiency leading to secondary hyperparathyroidism. Despite good medical management, this disease can progress and necessitate surgical management. This case affirms that subtotal parathyroidectomy and transcervical thymectomy have a role in the management of tumoral calcinosis, and may lead to excellent post-operative results.
